CCMP Capital
 |
|
| Limited Partnership | |
| Industry | Private Equity |
| Founded | 1984 (2006 Spinout from JPMorgan Chase) |
| Headquarters |
245 Park Avenue New York City, New York, United States |
|
Key people
|
Greg Brenneman, CEO Stephen Murray, President and Chief Executive Officer |
| Products | Leveraged buyout, Growth capital, Private equity funds |
| Total assets | $12 billion |
| Website | www |
CCMP Capital is an American private equity investment firm that focuses on leveraged buyout and growth capital transactions. Formerly known as JP Morgan Partners, the investment professionals of JP Morgan Partners separated from JPMorgan Chase on July 31, 2006. CCMP has invested approximately $12 billion in leveraged buyout and growth capital transactions since inception. In 2007, CCMP was ranked #17 among World's largest private equity funds.
CCMP has over 50 employees with offices in New York, London, Hong Kong and Tokyo. In 2008, CCMP hired Greg Brenneman as chairman.
CCMP has been known by several names over the past two decades, founded as Chemical Venture Partners in 1984, to serve as the private equity and venture capital arm of Chemical Bank.
Following Chemical's acquisition of Chase Manhattan Bank in 1996, Chemical adopted the Chase name and Chemical Venture Partners changed its name to Chase Capital Partners. Similarly, following the 2000 acquisition of J.P. Morgan & Co. and the formation of JPMorgan Chase, the group changed its name yet again to JP Morgan Partners. Over this time, the platform grew through its integration of the private equity organizations of Manufacturers Hanover, Chase Manhattan, Hambrecht & Quist, Robert Fleming & Co., The Beacon Group and J.P. Morgan & Co.
...
Wikipedia